- In a recent announcement Clifford A. Hudis of MSKCC will become the President of the American Society of Clinical Oncology (ASCO).
- Lloyd Old, a researcher and former administrator of two cancer research institutes, passed away the week of December 2.
- Researchers from MSKCC, Weill Cornell, and the National Cancer Institute developed a new method that reveals complete set of aberrant signaling pathways that give rise to cancers.
- Dr. Behfar Ehdaie of MSKCC is the lead author of a study that shows Hormone-targeted therapy for prostate cancer may raise the risk of potentially dangerous blood clots.